These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 16367740

  • 1. Hepatitis C virus (HCV) core protein enhances the immunogenicity of a co-delivered DNA vaccine encoding HCV structural antigens in mice.
    Alvarez-Lajonchere L, González M, Alvarez-Obregón JC, Guerra I, Viña A, Acosta-Rivero N, Musacchio A, Morales J, Dueñas-Carrera S.
    Biotechnol Appl Biochem; 2006 Apr; 44(Pt 1):9-17. PubMed ID: 16367740
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein are reversed by genetic immunizations augmented with cytokine-expressing plasmids.
    Geissler M, Gesien A, Wands JR.
    J Immunol; 1997 Nov 15; 159(10):5107-13. PubMed ID: 9366440
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids.
    Geissler M, Gesien A, Tokushige K, Wands JR.
    J Immunol; 1997 Feb 01; 158(3):1231-7. PubMed ID: 9013964
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of immunization in mice with recombinant DNA encoding the hepatitis C virus structural protein.
    Dou J, Liu K, Chen Z, Wo J, He N, Liu Y, Zhang M, Wang X, Xu C.
    Chin Med J (Engl); 1999 Nov 01; 112(11):1036-9. PubMed ID: 11721468
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development of a heterologous, multigenotype vaccine against hepatitis C virus infection.
    Encke J, Radunz W, Eisenbach C, Geib J, Gehrke S, Pfaff E, Stremmel W.
    Eur J Clin Invest; 2007 May 01; 37(5):396-406. PubMed ID: 17461986
    [Abstract] [Full Text] [Related]

  • 17. Activation of refractory T cell responses against hepatitis C virus core protein by ablation of interfering hydrophobic domains.
    Andersson HA, Singh RA, Barry MA.
    Mol Ther; 2006 Feb 01; 13(2):338-46. PubMed ID: 16242998
    [Abstract] [Full Text] [Related]

  • 18. Immune responses to hepatitis C virus structural and nonstructural proteins induced by plasmid DNA immunizations.
    Gordon EJ, Bhat R, Liu Q, Wang YF, Tackney C, Prince AM.
    J Infect Dis; 2000 Jan 01; 181(1):42-50. PubMed ID: 10608749
    [Abstract] [Full Text] [Related]

  • 19. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
    Luo M, Tao P, Li J, Zhou S, Guo D, Pan Z.
    J Virol Methods; 2008 Dec 01; 154(1-2):121-7. PubMed ID: 18789973
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.